Lane Labs FTC Settlement To Fund National Cancer Institute Study
This article was originally published in The Tan Sheet
Executive Summary
Lane Labs has been ordered by the Federal Trade Commission to contribute $450,000 to fund a National Cancer Institute clinical study on the effects of shark cartilage supplementation on cancer as part of a $1 mil. settlement of charges it made unsubstantiated cancer claims for its dietary supplements.
You may also be interested in...
Lane Labs To Pay Consumer Restitution Under Permanent Injunction
The seven-year struggle between FDA and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 9
Lane Labs To Pay Consumer Restitution Under Permanent Injunction
The seven-year struggle between FDA and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 9
Lane Labs To Pay Consumer Restitution Under Permanent Injunction
The seven-year struggle between FDA and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 9